|
MAP3K7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.18310000002597E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.65569999999571E-05 |
| Normal-vs-Stage2 |
3.406400E-04 |
| Normal-vs-Stage3 |
5.51159999999662E-05 |
| Normal-vs-Stage4 |
2.641500E-04 |
| Stage1-vs-Stage2 |
3.194800E-01 |
| Stage1-vs-Stage3 |
4.766800E-01 |
| Stage1-vs-Stage4 |
5.762800E-01 |
| Stage2-vs-Stage3 |
6.663600E-01 |
| Stage2-vs-Stage4 |
6.979400E-01 |
| Stage3-vs-Stage4 |
9.920000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95566999999786E-05 |
| Normal-vs-AfricanAmerican |
2.739200E-01 |
| Normal-vs-Asian |
7.033800E-04 |
| Caucasian-vs-AfricanAmerican |
1.342250E-01 |
| Caucasian-vs-Asian |
7.917000E-01 |
| AfricanAmerican-vs-Asian |
1.281990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6630000000406E-06 |
| Normal-vs-Female |
4.36689999999684E-05 |
| Male-vs-Female |
9.080100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.000000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.52342999999444E-05 |
| Normal-vs-Age(61-80Yrs) |
4.15500000000568E-05 |
| Normal-vs-Age(81-100Yrs) |
1.460060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.496200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.771360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.821000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.978800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.301400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.350400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.604800E-01 |
| Classical-VS-Follicular |
2.434700E-04 |
| Classical-VS-Other |
1.371580E-01 |
| Classical-VS-Normal |
3.804100E-03 |
| Tall-VS-Follicular |
6.557600E-02 |
| Tall-VS-Other |
2.137400E-01 |
| Tall-VS-Normal |
1.773750E-02 |
| Follicular-VS-Other |
8.135000E-01 |
| Follicular-VS-Normal |
3.70450000009015E-07 |
| Other-VS-Normal |
4.819200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.15730000033376E-07 |
| Normal-vs-N1 |
8.752700E-04 |
| N0-vs-N1 |
7.671000E-01 |
|
|
